Small font size A Larger text size A Largest text size A

Indivior Pharmaceuticals Plans $400 Million Private Debt Offering; Shares Down Pre-Bell

BY MT Newswires | CORPORATE | 03/12/26 07:50 AM EDT

07:50 AM EDT, 03/12/2026 (MT Newswires) -- Indivior Pharmaceuticals (INDV) said Thursday it plans a $400 million private offering of convertible senior unsecured notes due March 15, 2031.

The company expects to grant the initial purchasers a 30-day option to buy up to an additional $60 million of the notes.

Indivior said it plans to use the net proceeds to help repay borrowings under and terminate the note purchase agreement that governs its term loan and revolving credit facility, among other things.

The company's shares were down 5.3% in premarket activity.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

More Fixed Income News

G7 finance chiefs say it is urgent to limit Middle East war's cost to global economy BY Reuters |ECONOMIC 05:34 PM EDT
BRIEF-Inventrust Properties Corp. Enters Into A Private Placement Offering Of $250 Million Senior Unsecured Notes BY Reuters |CORPORATE 05:30 PM EDT
InvenTrust Properties Corp. Enters into a Private Placement Offering of $250 Million Senior Unsecured Notes BY Business Wire |CORPORATE 05:28 PM EDT
Moody's puts Corpus Christi under downgrade review again BY SourceMedia Bond Buyer |MUNICIPAL 05:21 PM EDT

All Fixed Income News

In general the bond market is volatile, and fixed income securities carry interest rate risk. (As interest rates rise, bond prices usually fall, and vice versa. This effect is usually more pronounced for longer-term securities.) Fixed income securities also carry inflation risk and credit and default risks for both issuers and counterparties. Unlike individual bonds, most bond funds do not have a maturity date, so avoiding losses caused by price volatility by holding them until maturity is not possible.

Lower-quality debt securities generally offer higher yields, but also involve greater risk of default or price changes due to potential changes in the credit quality of the issuer. Any fixed income security sold or redeemed prior to maturity may be subject to loss.

Before investing, consider the funds' investment objectives, risks, charges, and expenses. Contact Fidelity for a prospectus or, if available, a summary prospectus containing this information. Read it carefully.

fir_news_article